Sartorius AG

SRT: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
pk!LOCK|kLLOCK|BZBG%hC

Maintain Wide Moat Rating for Sartorius AG and Sartorius Stedim Biotech After Taking a Fresh Look

We are transferring coverage of Sartorius AG and its subsidiary Sartorius Stedim Biotech—both active in biopharmaceutical equipment and laboratory consumables—to a new analyst. Sartorius Stedim Biotech accounts for approximately 80% of group revenue and 89% of EBIT.

Sponsor Center